| J9271 | Injection, pembrolizumab, 1 mg | 11,500 | $40 | $494.5K |
| J9299 | Injection, nivolumab, 1 mg | 10,180 | $20 | $244.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 340 | $110 | $36K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 290 | $90 | $27.1K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 110 | $140 | $14.3K |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 120 | $80 | $9.2K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 4,270 | $1 | $8.5K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 420 | $20 | $8.3K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 130 | $60 | $7.5K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 50 | $130 | $6.6K |